Profil
Erik D.
Wiberg formerly worked at ALZA Corp., as Vice President-Business Development from 2001 to 2006, Catalyst Bioscience, Inc., as Chief Financial Officer, Anacor Pharmaceuticals LLC, as Vice President-Business Development from 2010 to 2015, Smith Barney & Co., Inc., as Principal, and Coherus BioSciences, Inc., as Executive Vice President-Corporate Development.
Mr. Wiberg received his undergraduate degree from The Wharton School of the University of Pennsylvania and undergraduate degree from School of Engineering & Applied Science.
Anciens postes connus de Erik D. Wiberg
| Sociétés | Poste | Fin |
|---|---|---|
| ALZA CORPORATION | Corporate Officer/Principal | 01/01/2006 |
| COHERUS BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA. | Directeur Financier/CFO | - |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
| Smith Barney & Co., Inc. | Corporate Officer/Principal | - |
Formation de Erik D. Wiberg
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| School of Engineering & Applied Science | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COHERUS BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
| Smith Barney & Co., Inc. | Finance |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Catalyst Bioscience, Inc. /Old/
Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
